Close

Regeneron (REGN), Sanofi (SNY) Announce FDA Approval of Kevzara for RA

May 22, 2017 5:46 PM EDT Send to a Friend
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NYSE: SNY) today announced the U.S. Food and Drug Administration (FDA) approval ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login